These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16181532)

  • 1. [Effect of Astragalus injection on plasma levels of apoptosis-related factors in aged patients with chronic heart failure].
    Zhang JG; Yang N; He H; Wei GH; Gao DS; Wang XL; Wang XZ; Song GY
    Chin J Integr Med; 2005 Sep; 11(3):187-90. PubMed ID: 16181532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of astraglus injection on serum apoptosis relevant factors in patients with chronic heart failure].
    Zhang JG; Yang N; He H
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 May; 25(5):400-3. PubMed ID: 15957829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure.
    Nishigaki K; Minatoguchi S; Seishima M; Asano K; Noda T; Yasuda N; Sano H; Kumada H; Takemura M; Noma A; Tanaka T; Watanabe S; Fujiwara H
    J Am Coll Cardiol; 1997 May; 29(6):1214-20. PubMed ID: 9137215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas ligand system in patients with chronic heart failure.
    Adamopoulos S; Parissis J; Karatzas D; Kroupis C; Georgiadis M; Karavolias G; Paraskevaidis J; Koniavitou K; Coats AJ; Kremastinos DT
    J Am Coll Cardiol; 2002 Feb; 39(4):653-63. PubMed ID: 11849865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proinflammatory cytokine activation is linked to apoptotic mediator, soluble Fas level in patients with chronic heart failure.
    Kinugawa T; Kato M; Yamamoto K; Hisatome I; Nohara R
    Int Heart J; 2012; 53(3):182-6. PubMed ID: 22790687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ongoing myocardial damage in chronic heart failure is related to activated tumor necrosis factor and Fas/Fas ligand system.
    Setsuta K; Seino Y; Ogawa T; Ohtsuka T; Seimiya K; Takano T
    Circ J; 2004 Aug; 68(8):747-50. PubMed ID: 15277733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone-induced reduction of soluble apoptosis mediators is associated with reverse cardiac remodelling and improvement of exercise capacity in patients with idiopathic dilated cardiomyopathy.
    Parissis JT; Adamopoulos S; Karatzas D; Paraskevaidis J; Livanis E; Kremastinos D
    Eur J Cardiovasc Prev Rehabil; 2005 Apr; 12(2):164-8. PubMed ID: 15785303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone administration reduces circulating proinflammatory cytokines and soluble Fas/soluble Fas ligand system in patients with chronic heart failure secondary to idiopathic dilated cardiomyopathy.
    Adamopoulos S; Parissis JT; Georgiadis M; Karatzas D; Paraskevaidis J; Kroupis C; Karavolias G; Koniavitou K; Kremastinos DT
    Am Heart J; 2002 Aug; 144(2):359-64. PubMed ID: 12177657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of astragalus injection on immune function in patients with congestive heart failure].
    Liu ZG; Xiong ZM; Yu XY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 May; 23(5):351-3. PubMed ID: 12800417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on effect of Astragalus injection in treating congestive heart failure].
    Zhou ZL; Yu P; Lin D
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Oct; 21(10):747-9. PubMed ID: 12575607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of astragalus on cardiac function and serum tumor necrosis factor-alpha level in patients with chronic heart failure].
    Yang QY; Lu S; Sun HR
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Jul; 30(7):699-701. PubMed ID: 20929124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in immunocyte tumor necrosis factor receptor and apoptosis in patients with congestive heart failure.
    Rumalla VK; Calvano SE; Spotnitz AJ; Krause TJ; Hilkert RJ; Lin E; Lowry SF
    Ann Surg; 2002 Aug; 236(2):254-60. PubMed ID: 12170032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
    Adamopoulos S; Parissis JT; Iliodromitis EK; Paraskevaidis I; Tsiapras D; Farmakis D; Karatzas D; Gheorghiade M; Filippatos GS; Kremastinos DT
    Am J Cardiol; 2006 Jul; 98(1):102-6. PubMed ID: 16784930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of darbepoetin-alpha on plasma pro-inflammatory cytokines, anti-inflammatory cytokine interleukin-10 and soluble Fas/Fas ligand system in anemic patients with chronic heart failure.
    Kourea K; Parissis JT; Farmakis D; Panou F; Paraskevaidis I; Venetsanou K; Filippatos G; Kremastinos DT
    Atherosclerosis; 2008 Jul; 199(1):215-21. PubMed ID: 17991471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma concentration of Fas/Fas ligand and left ventricular function in response to metoprolol in conjunction with standard treatment.
    Hou YP; Wu JL; Fan Q; Liu MB; Yin BL; Zhang L
    Clin Sci (Lond); 2007 Mar; 112(5):299-304. PubMed ID: 17020540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in advanced melanoma.
    Mouawad R; Khayat D; Soubrane C
    Melanoma Res; 2000 Oct; 10(5):461-7. PubMed ID: 11095407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of plasma levels of tumor necrosis factor-alpha and interleukin-6 in predicting the severity and prognosis in patients with congestive heart failure.
    Pan JP; Liu TY; Chiang SC; Lin YK; Chou CY; Chan WL; Lai ST
    J Chin Med Assoc; 2004 May; 67(5):222-8. PubMed ID: 15357108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of soluble FAS, FAS ligand and tumour necrosis factor-alpha in patients with chronic HCV infection.
    Raghuraman S; Abraham P; Daniel HD; Ramakrishna BS; Sridharan G
    J Clin Virol; 2005 Sep; 34(1):63-70. PubMed ID: 16087126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An increase of soluble Fas, an inhibitor of apoptosis, associated with progression of COPD.
    Yasuda N; Gotoh K; Minatoguchi S; Asano K; Nishigaki K; Nomura M; Ohno A; Watanabe M; Sano H; Kumada H; Sawa T; Fujiwara H
    Respir Med; 1998 Aug; 92(8):993-9. PubMed ID: 9893764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma soluble fas and soluble fas ligand in chronic glomerulonephritis.
    Sano H; Asano K; Minatoguchi S; Hiraoka J; Fujisawa K; Nishigaki K; Yasuda N; Kumada H; Takemura M; Ohashi H; Seishima M; Fujiwara T; Fujiwara H
    Nephron; 1998 Oct; 80(2):153-61. PubMed ID: 9736812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.